By midmorning, shares had added 1.8% to $98.89.
Over the three months to March, the company reported earnings of $1.54 a share and revenue of $18.11 billion. Analysts surveyed by Thomson Reuters anticipated net income of $1.48 a share and revenue of $18 billion.
For the full year, the company guides for earnings between $5.80 and $5.90 a share. Analysts expected an average of $5.83 a share.
TheStreet Ratings team rates JOHNSON & JOHNSON as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:
"We rate JOHNSON & JOHNSON (JNJ) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook."
Highlights from the analysis by TheStreet Ratings Team goes as follows: